Results of treatment of myopia progression by the method of cryogenic scleroplasty

Cover Page


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

AIM: To evaluate the results of the effectiveness of cryogenic scleroplasty.

MATERIALS AND METHODS: 184 children (313 eyes) (mean age 11,72 ± 3,76 years) with moderate and high progressive myopia were examined before and after cryogenic scleroplasty (main group) and Pivovarov’s scleroplasty (control group).

RESULTS: A smaller average annual difference in the spherical equivalent of refraction (∆SEav) and the average annual gradient of the axial length (∆ALav) were recorded in the group of patients after cryogenic scleroplasty according to the data obtained during the two-year follow-up. ∆SEav was –0,48 ± 0,45 diopters in the main group and –0,51 ± 0,34 diopters in the control group in children of the younger age subgroup (up to 9 years old); –0,35 ± 0,31 diopters in the main group and –0,69 ± 0,61 diopters in the control group (p = 0,047) in the older age subgroup (9 years and older). ∆ALav in the main group was 0,15 ± 0,11 mm in children under 9 years of age, 0,31 ± 0,14 mm (p = 0,016) in the control group; 0,29 ± 0,18 mm and 0,34 ± 0,32 mm in children 9 years old and older, respectively.

CONCLUSIONS: The proposed technology of cryogenic scleroplasty has two surgical approaches in the lower-internal and upper-external parts of the eyeball; the scleroplastic material adheres evenly to the sclera, covers all four quadrants of the eyeball; it is fixed under the rectus muscles of the eye; at a 24-months follow-up period showed a good stabilizing effect.

Full Text

INTRODUCTION

Progressive myopia is a known global medical and social problem. With an unfavorable course, the risk of serious complications, leading to a decrease in visual functions that are not amenable to optical and surgical correction, increases substantially [1–3]. An analysis of the results of 145 studies involving 2.1 million people predicts that by 2050 there would be a significant increase in the prevalence of myopia worldwide, and 938 million people would have high myopia [4].

At present, many theories attempted to explain the development and progression of myopia [5, 6]. Along with optical disorders, the involvement of the scleral factor in the pathogenesis of progressive myopia is undisputable. Through biomechanical studies, E. Iomdina reported that “… with the progression of myopia, the range of elastic deformations of the sclera is reduced, and even under physiological stress, its plastic deformations accumulate gradually, which results in irreversible stretching of the membranes and an increase in the axial length of the eye.” Moreover, in the sclera, mainly in the region of the equator and the posterior pole, collagen metabolism is disturbed in the form of a decrease in the content of total collagen, an increase in the level of its soluble fractions, and a significant decrease in glycosaminoglycans and in the level of intra- and intermolecular cross-links that stabilize the connective tissue structures of the sclera [7]. Obviously, increase in the axial length (AL) and thinning of the sclera does not stimulate an adequate response from the more highly differentiated tunics of the eye (uvea and retina). They are not capable of such stretching and respond by a dystrophic process, and this eventually reduces all visual functions. Considering the polyetiologic nature of myopia, the treatment of progressive myopia should undoubtedly be comprehensive, including medical, functional (using visual training equipment), and optical methods of treatment and providing sclera reinforcement surgeries that improve the hemodynamics of the eye, generate a tissue biostimulating effect with the production of biologically active substances, activate collagen synthesis in the sclera, and increase its biomechanical stability [8–11]. Sclera reinforcement surgeries slow down the process of membrane stretching, slow down the progression rate, and delay or even prevent the development of dystrophic complications [8, 12]. Existing diversity of surgical sclera reinforcement methods [13–16] are indicative of the search for safe and effective methods to stabilize myopia progression.

This study aimed to analyze the efficiency of cryogenic scleroplasty in patients with progressive myopia.

MATERIALS AND METHODS

The study included 184 pediatric patients with progressive myopia aged 7–16 years (on average 11.72± 3.76 years), who underwent surgery at the Cheboksary branch of S.N. Fyodorov Eye Microsurgery Complex, interbranch scientific and technical complex of eye microsurgery of the Ministry of Health of Russia. Of these patients, 84 (45.65%) were boys and 100 (54.35%) were girls. The follow-up period was 2 years. The children underwent a comprehensive ophthalmological examination including ophthalmometry, refractometry, visometry with assessment of uncorrected and best corrected visual acuity before and after cycloplegia, optical biometry including AL registration with the IOL Master 500 biometer (Carl Zeiss, Germany), tonometry, biomicroscopy, ophthalmoscopy, examination of the fundus periphery with Goldman or Osher lenses, measurement of protein and inflammatory cells present in the anterior chamber fluid with the FC-2000 Tyndall meter (Kowa, Japan), as well as the study of ocular motility, determination of the character of vision with the Forbis apparatus, and Belostotsky–Friedman four-point color test.

The main group included 96 pediatric patients (167 eyes) who underwent cryogenic scleroplasty [17, 18], while the control group included 88 pediatric patients (146 eyes) who underwent standard Pivovarov scleroplasty. The study groups demonstrated comparable preoperative characteristics (Table 1). In 44 eyes (14% of the pediatric patients), prophylactic laser photocoagulation of the retina was previously performed for peripheral chorioretinal dystrophy.

 

Table 1. Study groups characteristic, М±

Таблица 1. Характеристика исследуемых групп, М±m

Parameter

Main group

Control group

Total number of children (eyes)

96 (167)

88 (146)

Age, years

11.91±2.78

11.66±2.46

Spherical refraction, diopters

–5.85±2.22

[–4.5; –11.5]

–5.67±1.54

[–3.5; –10.75]

Cylindrical refraction, diopters

–1.04± 0.68

–0.96±0.49

Axial length (AL), mm

25.98±0.72

[24.40; 27.87]

25.83± 0.86

[24.01; 27.95]

Uncorrected visual acuity (UCVA)

0.04±0.02

0.04±0.02

Best corrected visual acuity (BCVA)

0.83±0.19

0.84±0.75

 

According to the literature, AL increase is also noted in eyes with emmetropia, which is considered normal. The gradient of the increase in the AL of healthy children in the younger age group (7–8 years old) was 0.58 mm, and that in the older age group (9–10 years old) was 0.44 mm. In children with myopia, this indicator was nearly 2.5 times higher than that in children with emmetropia (1.55± 0.67 and 1.13± 0.32 mm, respectively) [18]. Given these values, for a correct assessment of changes in AL and refraction, children, taking into account standard values for their age, were distributed into two age subgroups (aged ≤9 years and ≥9 years).

Cryogenic scleroplasty involves the following:

1) Creation of an operative access in the lower nasal and upper temporal quadrants of the eyeball by separating the conjunctiva and Tenon’s capsule from the sclera (Fig. 1)

 

Fig. 1. Scheme of the location of the incisions of the conjunctiva and tenon capsule (left eye). 1 – in the inferio-nasal quadrant, 2 – in the superio-temporal quadrant

Рис. 1. Схема расположения разрезов конъюнктивы и теноновой оболочки (левый глаз). 1 — в нижне-носовом квадранте, 2 — в верхне-височном квадранте

 

2) After an exposure to liquid nitrogen for 10 seconds, the scleroplastic material is placed under the rectus muscles of the eye at an angle of 45° (Figs. 2 and 3).

 

Fig. 2. Layout diagram transplants in the inferio-nasal quadrant (left eye). 1 – m. rectus inferior, 2 – m. rectus medialis

Рис. 2. Схема расположения трансплантатов в нижне-носовом квадранте (левый глаз). 1 — нижняя прямая мышца, 2 — медиальная прямая мышца

 

Fig. 3. Layout diagram transplants in the superio-temporal quadrant (left eye). 1 – m. rectus lateralis, 2 – m. rectus superior

Рис. 3. Схема расположения трансплантатов в верхне-височном квадранте (левый глаз). 1 — латеральная прямая мышца, 2 — верхняя прямая мышца

 

In the lower nasal quadrant, the conjunctiva and Tenon’s membrane are cut in layers perpendicular to the limbus. Tenon’s capsule is separated from the underlying episclera to form a pocket under the lower and medial rectus muscles. A transplant (NEP MG, Moscow, TU 9398-001-29039336-2011), measuring 20 × 10 mm, is inserted under the lower rectus muscle after preliminary exposure to liquid nitrogen solution for 10 seconds. Through the same incision, the second scleroplastic material, after exposure to the liquid nitrogen solution, is inserted under the medial rectus muscle. In this case, the grafts were immersed behind the equator at an angle of 45° to the inferior and medial rectus muscles. The second incision of the conjunctiva is made in the superior temporal quadrant. The scleroplasty material exposed to liquid nitrogen solution is inserted under the lateral rectus muscle and immersed behind the equator at an angle of 45° to the muscle. Through the same incision, the next graft is placed behind the equator: its upper end is immersed under the superior rectus muscle, and the lower end is oriented in an oblique direction at an angle of 45° toward the lateral rectus muscle to close the area of attachment of the superior oblique muscle. Then, 8/0 buried sutures are applied to the conjunctival incisions (please see the video “Cryogenic scleroplasty,” https://journals.eco-vector.com/ov/copyeditor/downloadFile/59309/131708).

RESULTS AND DISCUSSION

All surgeries were performed without any complications. The postoperative period was practically uneventful, and there were no adverse reactions to the scleroplastic material used. In the first postoperative days, some pediatric patients had a minor photophobia and a moderate pain reaction at eyeball movements. The severity of these manifestations in the studied groups was nearly the same. In two patients of the main group (2%), minor conjunctival chemosis was registered. The vision remained binocular, and ocular movements were not restricted. Postoperative Tyndallometry parameters in the study groups remained within the normal limits; the average protein flux was 3.6±0.07 f/ms in the main group and 3.4±1.6 f/ms in the control group (normal values up to 5 f/ms).

AL and objective refraction could be considered as main indicators in the control of myopia progression [8]. Based on 2-year follow-up data, in pediatric patients of subgroup 1, the average annual difference in the spherical equivalent of refraction (∆SEav) was –0.48±0.45 diopters in the main group and –0.51± 0.34 diopters in the control group. In subgroup 2, the changes in ∆SEav in the main group and control group were –0.35± 0.31 diopters and –0.69±0.61 diopters, respectively (Table 2).

 

Table 2. Average annual difference in the spheroequivalent of refraction. D (∆SEav)

Таблица 2. Среднегодовая разница сфероэквивалента рефракции. дптр (∆СЭср)

Subgroup

Follow-up

Main group

Control group

1

Before surgery

–4.84±1.4

–4.91±1.12

1 year

–5.16±1.34

–5.47±1.13

2 years

–5.60±1.35

–5.84±2.24

D (∆SEav)

–0.48±0.45

–0.51±0.34

р= 1.0

2

Before surgery

–6.25±1.96

–6.01±1.81

1 year

–6.53±2.10

–6.61±1.83

2 years

–6.78±1.99

–6.96±2.24

D (∆SEav)

–0.35±0.31

–0.69±0.61

р= 0.047

 

The average annual AL gradients (∆ALav) in pediatric patients of the subgroup 1 of the main group and of the control group were 0.15± 0.11 mm and 0.31± 0.14 mm, respectively. In subgroup 2, the values were 0.29± 0.18 and 0.34± 0.32 mm, respectively (Table 3).

 

Table 3. Average annual gradient аxial length (∆ALav)

Таблица 3. Средний годовой градиент переднезадней оси (∆ПЗОср)

Subgroup

Follow-up

Main group

Control group

Children with emmetropia

1

Before surgery

25.12±0.32

25.09±0.58

1 year

25.23±0.65

25.47±0.35

2 years

25.40±0.33

25.73±0.29

∆ALav

0.15±0.11

0.31±0.14

0.132±0.02*

р= 0.016

2

Before surgery

25.96±0.66

25.84±1.55

1 year

26.24±0.21

26.26±1.11

2 years

26.55±0.72

26.59±0.29

∆ALav

0.29±0.18

0.34±0.32

0.076±0.07*

р= 0.74

*Sitka M.M. Sravnitel’nyj analiz razlichnyh sposobov dolgosrochnoj opticheskoj korrekcii progressirujushhej miopii u detej i podrostkov (Comparative analysis of Optical Correction Methods for Progressive Myopia in Children and Adolescents) [thesis], Moscow, 2018. 158 p.

 

The results of this study reveal that patients who underwent cryogenic scleroplasty demonstrated a lower average annual difference in the spherical equivalent of refraction (statistically significant in the subgroup aged ≥9 years) and the average annual gradient AL (statistically significant in the subgroup aged ≤9 years). Graft’s exposure to liquid nitrogen solution keeps its shape, and the graft was not deformed during immersion and placement on the scleral surface. Its location under the muscles ensures a tight contact with the sclera and fixation of flaps. Local hypothermia after vascular spasm leads to vasodilatation with an increase in the intensity of local blood flow, and increases aseptic inflammation and immune response to transplantation and surgery. All of the above contributes to a more durable fusion of the graft with the sclera and ultimately determines the biomechanical stability of the “sclera–graft” complex.

CONCLUSION

In this study, the developed technique of cryogenic scleroplasty as surgical treatment for progressive myopia has two, instead of the traditional four, operative accesses, that is, approaches via the lower nasal and upper temporal parts of the eyeball. The scleroplastic material is fixed under rectus muscles, covers all four quadrants of the eyeball, and evenly adheres to the sclera. With a follow-up period of 24 months, a stabilizing effect was observed.

ADDITIONAL INFORMATION

Author contributions. N.P. Pashtaev created the concept and study design, performed scientific and methodological editing, surgical treatment, and provided final approval of the article version for publication. I.N. Gri gorieva collected and processed the material, performed the diagnostic research, wrote the text, and reviewed the literature.

Funding. Funding source was not specified.

Conflict of interest. The authors declare no conflict of interest.

×

About the authors

Nikolay P. Pashtaev

S.N. Fedorov Eye Microsurgery Federal State Institution, the Cheboksary Branch; I.N. Ulyanov Chuvash State University

Author for correspondence.
Email: pashtaevnp@gmail.com
ORCID iD: 0000-0003-2324-8044
SPIN-code: 9629-3161

Dr. Sci. (Med.), professor

Russian Federation, 10, Traktorostroiteley str., Cheboksary, 428028; Cheboksary

Irina N. Grigorieva

S.N. Fedorov Eye Microsurgery Federal State Institution, the Cheboksary Branch

Email: grigir09@mail.ru
ORCID iD: 0000-0003-1107-9810
SPIN-code: 4635-3437

ophthalmologist

Russian Federation, 10, Traktorostroiteley str., Cheboksary, 428028

References

  1. Neroev VV. Eye care management in russian federation. The Russian Annals of Ophthalmology. 2014;130(6):8–12. (In Russ.)
  2. Katargina LA, Mikhailova LA. The current stage of the ophthalmological care service in the Russian Federation (2012–2013). Russian Pediatric Ophthalmology. 2015;(1):5–10. (In Russ.)
  3. Fricke TR, Jong M, Naidoo KS, et al. Global prevalence of visual impairment associated with myopic macular degeneration and temporal trends from 2000 through 2050: systematic review, meta-analysis and modelling. Br J Ophthalmol. 2018;102(7):855–862. doi: 10.1136/bjophthalmol-2017-311266
  4. Holden BA, Fricke TR, Wilson DA, et al. Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Ophthalmology. 2016;123(5):1036–1042. doi: 10.1016/j.ophtha.2016.01.006.
  5. Tarutta EP, Proskurina OV, Tarasova NA, et al. Myopia predictors as a starting point for active prevention of myopia development. Russian Ophthalmological Journal. 2018;11(3):107–112. (In Russ.) doi: 10.21516/2072-0076-2018-11-3-107-112
  6. Tarutta EP, Proskurina OV, Markossian GA, et al. A strategically oriented conception of optical prevention of myopia onset and progression. Russian Ophthalmological Journal. 2020;13(4):7–16. (In Russ.) doi: 10.21516/2072-0076-2020-13-4-7-16
  7. Iomdina EN. Biomehanika skleral’noj obolchki glaza pri miopii: diagnostika narushenij i ih jeksperimental’naja korrekcija [dissertation]. Moscow, 2000. 48 p. Available from: https://www.elibrary.ru/item.asp?id=30190377. (In Russ.)
  8. Avetisov SE, Kashhenko TP, Shamshinova AM. Zritel’nye funkcii i ih korrekcija u detej: rukovodstvo dlja vrachej. Moscow: Medicina, 872 p. (In Russ.)
  9. Kornilovskij IM. Patogeneticheskie aspekty stabilizacii miopii posle skleroplasticheskih operacij. Journal of Ophthalmology. 1987;42(6):343–347. (In Russ.)
  10. Tarutta EP, Markossian GA, Sianosyan AA, Milash SV. Choroidal thickness in varied types of refraction and its changes after sclera strengthening surgeries. Russian Ophthalmological Journal. 2017;10(4): 48–53. (In Russ.) doi: 10.21516/2072-0076-2017-10-4-48-53
  11. Iomdina EN, Andreeva LD. Biomehanicheskoe i morfologicheskoe izuchenie otdalennyh rezul’tatov skleroukrepljajushhej injekcii v jeksperimente. In: Patologija opticheskih sred. Moscow; 1989. P. 127–130. (In Russ.)
  12. Avetisov SE, Fridman FE, Saksonova EO, et al. Rol’ rastjazhenija sklery v geneze miopicheskih vitreohorioretinal’nyh distrofij. Journal of Ophthalmology. 1988;43(3):137–138. (In Russ.)
  13. Eliseeva EV. Skleroukrepljajushhie operacii: uchebnoe posobie. Karaganda, 2007. (In Russ.)
  14. Tarutta EP. Vybor metoda skleroplastiki pri progressirujushhej blizorukosti u detej. The Russian Annals of Ophthalmology. 1992;108(2):10–13. (In Russ.)
  15. Gerinec A, Slezakova G. Posterior scleroplasty in children with severe myopia. Bratisl Lek Lisky. 2001;102(2):73–80.
  16. Wollensak G, Iomdina Е. Long-term biomechanical properties of rabbit sclera after collagen crosslinking using riboflavin and ultraviolet A (UVA). Acta Ophthalmol. 2009;87:193–198. doi: 10.1111/j.1755-3768.2008.01229.x
  17. Patent RUS2697240/30.08.2018 Pashtaev. NP, Grigor’eva IN, Shahmatova IP. Sposob hirurgicheskogo lechenija progressirujushhej miopii. Available from: https://new.fips.ru/registers-doc-view/fips_servlet. (In Russ.)
  18. Pashtaev NP, Grigorieva IN. Preliminary results of modifed cryogenic scleroplasty. Saratov Journal of Medical Scientific Research. 2019;15(2):515–517. (In Russ.)
  19. Sitka MM, Bodrova SG, Tikhonova OI, et al. Assessment of influence of various eye parameters in emmetropia children on myopia development. Ophthalmology in Russia. 2020;17(2):263–268. (In Russ.). doi: 10.18008/1816-5095-2020-2-263-268

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig. 1. Scheme of the location of the incisions of the conjunctiva and tenon capsule (left eye). 1 – in the inferio-nasal quadrant, 2 – in the superio-temporal quadrant

Download (92KB)
3. Fig. 2. Layout diagram transplants in the inferio-nasal quadrant (left eye). 1 – m. rectus inferior, 2 – m. rectus medialis

Download (63KB)
4. Fig. 3. Layout diagram transplants in the superio-temporal quadrant (left eye). 1 – m. rectus lateralis, 2 – m. rectus superior

Download (81KB)

Copyright (c) 2021 Pashtaev N.P., Grigorieva I.N.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77-65574 от 04 мая 2016 г.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies